NFKB1 and acute myeloid leukemia: In both AML and MDS myeloblasts, pATM inhibition caused inhibition of NF-κB (loss of nuclear p65), coupled to the inactivation of the IKK complex and the redistribution of NEMO from the nucleus to the cytoplasm.